1. Home
  2. IDYA vs MSGE Comparison

IDYA vs MSGE Comparison

Compare IDYA & MSGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • MSGE
  • Stock Information
  • Founded
  • IDYA 2015
  • MSGE 2020
  • Country
  • IDYA United States
  • MSGE United States
  • Employees
  • IDYA N/A
  • MSGE N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • MSGE Services-Misc. Amusement & Recreation
  • Sector
  • IDYA Health Care
  • MSGE Consumer Discretionary
  • Exchange
  • IDYA Nasdaq
  • MSGE Nasdaq
  • Market Cap
  • IDYA 2.0B
  • MSGE 1.7B
  • IPO Year
  • IDYA 2019
  • MSGE N/A
  • Fundamental
  • Price
  • IDYA $21.85
  • MSGE $35.99
  • Analyst Decision
  • IDYA Strong Buy
  • MSGE Strong Buy
  • Analyst Count
  • IDYA 13
  • MSGE 5
  • Target Price
  • IDYA $53.67
  • MSGE $46.00
  • AVG Volume (30 Days)
  • IDYA 972.2K
  • MSGE 377.1K
  • Earning Date
  • IDYA 02-13-2025
  • MSGE 02-06-2025
  • Dividend Yield
  • IDYA N/A
  • MSGE N/A
  • EPS Growth
  • IDYA N/A
  • MSGE 84.36
  • EPS
  • IDYA N/A
  • MSGE 2.62
  • Revenue
  • IDYA $7,000,000.00
  • MSGE $960,518,000.00
  • Revenue This Year
  • IDYA $111.81
  • MSGE $1.53
  • Revenue Next Year
  • IDYA $240.55
  • MSGE $5.76
  • P/E Ratio
  • IDYA N/A
  • MSGE $13.75
  • Revenue Growth
  • IDYA N/A
  • MSGE 7.44
  • 52 Week Low
  • IDYA $19.96
  • MSGE $32.40
  • 52 Week High
  • IDYA $47.72
  • MSGE $44.14
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 43.52
  • MSGE 45.45
  • Support Level
  • IDYA $19.96
  • MSGE $36.65
  • Resistance Level
  • IDYA $21.65
  • MSGE $38.56
  • Average True Range (ATR)
  • IDYA 1.09
  • MSGE 1.11
  • MACD
  • IDYA -0.07
  • MSGE -0.09
  • Stochastic Oscillator
  • IDYA 33.57
  • MSGE 40.23

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.

About MSGE Madison Square Garden Entertainment Corp.

Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.

Share on Social Networks: